(CMT) Core Molding Technologies - Ratings and Ratios
Exchange: NYSE MKT • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2186831002
CMT: Thermoplastic, Thermoset, Molding, Compounds, Structural, Foam
Core Molding Technologies, Inc. (NYSE MKT:CMT) is a leading manufacturer of thermoplastic and thermoset structural products, serving diverse industrial markets. The company specializes in advanced molding technologies, including compression molding of sheet molding compound (SMC), resin transfer molding (RTM), and liquid molding of dicyclopentadiene (DCPD). Additionally, it utilizes spray-up and hand-lay-up processes, direct long-fiber thermoplastics (DLFT), and structural foam and structural web injection molding. These processes enable the production of high-performance, lightweight, and durable components for various applications. Core Molding Technologies primarily serves the medium and heavy-duty truck, automotive, power sport, construction, building products, industrial, utilities, and other commercial markets. Its geographic reach spans the United States, Mexico, Canada, and international regions. The company, originally known as Core Materials Corporation, rebranded as Core Molding Technologies, Inc. in August 2002. It was incorporated in 1996 and maintains its headquarters in Columbus, Ohio.
As a key player in the plastics and composites industry, Core Molding Technologies focuses on innovation and precision to meet stringent customer requirements. Its product portfolio includes structural components for vehicle bodies, frames, and other applications, where weight reduction, strength, and durability are critical. The companys expertise in thermoset and thermoplastic materials positions it as a reliable supplier to automotive and industrial manufacturers. With a strong emphasis on quality control and process optimization, Core Molding Technologies ensures consistent delivery of high-quality products. Its operational footprint includes multiple manufacturing facilities equipped with state-of-the-art equipment, enabling efficient production and scalability to meet growing demand.
3-Month Forecast: Based onAdditional Sources for CMT Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CMT Stock Overview
Market Cap in USD | 123m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Commodity Chemicals |
IPO / Inception | 1988-09-16 |
CMT Stock Ratings
Growth 5y | 47.2% |
Fundamental | 37.6% |
Dividend | 2.13% |
Rel. Strength Industry | -25.2 |
Analysts | 4/5 |
Fair Price Momentum | 14.22 USD |
Fair Price DCF | 76.15 USD |
CMT Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | 0.00% |
Payout Consistency | 7.1% |
CMT Growth Ratios
Growth Correlation 3m | -92% |
Growth Correlation 12m | -81.2% |
Growth Correlation 5y | 73.6% |
CAGR 5y | 46.68% |
CAGR/Max DD 5y | 0.83 |
Sharpe Ratio 12m | -0.74 |
Alpha | -35.77 |
Beta | 0.60 |
Volatility | 44.21% |
Current Volume | 46.3k |
Average Volume 20d | 35.9k |
As of March 14, 2025, the stock is trading at USD 13.60 with a total of 46,265 shares traded.
Over the past week, the price has changed by +0.00%, over one month by +0.89%, over three months by -16.62% and over the past year by -29.13%.
Partly, yes. Based on ValueRay Fundamental Analyses, Core Molding Technologies (NYSE MKT:CMT) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 37.55 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CMT as of March 2025 is 14.22. This means that CMT is currently overvalued and has a potential downside of 4.56%.
Core Molding Technologies has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy CMT.
- Strong Buy: 0
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, CMT Core Molding Technologies will be worth about 15.6 in March 2026. The stock is currently trading at 13.60. This means that the stock has a potential upside of +14.63%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 24 | 76.5% |
Analysts Target Price | 24 | 76.5% |
ValueRay Target Price | 15.6 | 14.6% |